Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 14
1994 38
1995 60
1996 37
1997 46
1998 64
1999 63
2000 85
2001 63
2002 63
2003 81
2004 88
2005 82
2006 105
2007 116
2008 113
2009 118
2010 129
2011 129
2012 144
2013 153
2014 177
2015 204
2016 209
2017 199
2018 199
2019 97
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

2,625 results
Results by year
Filters applied: . Clear all
Page 1
Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
Joo I, et al. Radiology 2018 - Review. PMID 29869969
In the detection, characterization, staging, and resectability assessment of cholangiocarcinoma, imaging studies are indispensable. ...In addition, classification systems, new pathologic concepts in cholangiocarcinogenesis and premalignant lesions, and current trends in treatment approaches, which are vital to the imaging interpretation of cholangiocarcinoma, will be discussed. (©) RSNA, 2018....
In the detection, characterization, staging, and resectability assessment of cholangiocarcinoma, imaging studies are indispensable. . …
Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
Rahnemai-Azar AA, et al. Surg Oncol 2017 - Review. PMID 28577718
Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor with increasing incidence worldwide. The outcome of patients with iCCA is dismal owing to tumor's aggressiveness, late diagnosis and lack of effective treatment options. ...Unfortunately, despite recent developments in imaging modalities and laboratory tests, the diagnosis of iCCA remains challenging and patients often present in advanced stages when surgery cannot be offered. ...
Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor with increasing incidence worldwide. The outcome …
Cholangiocarcinoma.
Squadroni M, et al. Crit Rev Oncol Hematol 2017 - Review. PMID 28693792
We distinguish cholangiocarcinoma (intrahepatic, hilar and distal) and gallbladder cancer, with different pathogenesis and prognosis. ...
We distinguish cholangiocarcinoma (intrahepatic, hilar and distal) and gallbladder cancer, with different pathogenesis and prognosis. …
Cholangiocarcinoma.
Khan AS and Dageforde LA. Surg Clin North Am 2019 - Review. PMID 30846037
Cholangiocarcinoma is a rare malignancy and accounts for 2% of all malignancies. Incidence is on the increase in the Western world. Cholangiocarcinoma arises from the malignant growth of the epithelial lining of the bile ducts and can be found all along the biliary tree. ...
Cholangiocarcinoma is a rare malignancy and accounts for 2% of all malignancies. Incidence is on the increase in the Western world.
Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.
Tshering G, et al. Am J Trop Med Hyg 2018. PMID 29637880 Free PMC article.
Cholangiocarcinoma (CCA), a malignant tumor of the bile duct, is a major public health problem in many Southeast Asian countries, particularly Thailand. The slow progression makes it difficult for early diagnosis and most patients are detected in advanced stages. This study aimed to review all relevant articles related to the biomarkers for the diagnosis of CCA and point out potential biomarkers. ...
Cholangiocarcinoma (CCA), a malignant tumor of the bile duct, is a major public health problem in many Southeast Asian countries, par
Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates.
Lee AJ and Chun YS. Chin Clin Oncol 2018 - Review. PMID 30180751 Free article.
Intrahepatic cholangiocarcinoma accounts for 5% to 30% of all primary liver cancers, and its incidence has increased in the last 3 decades. ...The 7th edition of the American Joint Committee on Cancer (AJCC) Staging Manual introduced a new staging system for intrahepatic cholangiocarcinoma, which was previously staged the same as hepatocellular carcinoma. ...
Intrahepatic cholangiocarcinoma accounts for 5% to 30% of all primary liver cancers, and its incidence has increased in the last 3 de …
Perioperative Management of Hilar Cholangiocarcinoma.
Poruk KE, et al. J Gastrointest Surg 2015 - Review. PMID 26022776 Free PMC article.
METHODS: We performed a comprehensive literature search using PubMed, Medline, and the Cochrane library for the period 1980-2015 using the following MeSH terms: "hilar cholangiocarcinoma", "biliary cancer", and "cholangiocarcinoma". ...The best chance of long-term survival and potential cure is surgical resection with negative surgical margins, but many patients are unresectable due to locally advanced or metastatic disease at diagnosis. ...
METHODS: We performed a comprehensive literature search using PubMed, Medline, and the Cochrane library for the period 1980-2015 using the f …
Molecular diagnosis of intrahepatic cholangiocarcinoma.
Haga H and Patel T. J Hepatobiliary Pancreat Sci 2015 - Review. PMID 25267595 Free PMC article.
There is a need for accurate and sensitive molecular markers for the diagnosis of iCCA. Recent advances in elucidating molecular and genetic characteristics of iCCA offer the potential of molecular-based diagnosis of iCCA. ...Although there are no accurate serum or biliary biomarkers currently available for diagnosis of iCCA, several potential candidates have been identified. ...
There is a need for accurate and sensitive molecular markers for the diagnosis of iCCA. Recent advances in elucidating molecular and …
Intrahepatic cholangiocarcinoma.
Nakano M, et al. Semin Diagn Pathol 2017. PMID 28094162
Cholangiocarcinoma, also referred to as cholangiocellular carcinoma (particularly in Japan), develops along the biliary tract. ...Guidelines for diagnosis and management of cholangiorcarcinoma, such as those proposed by EASL (European Association for the Study of the Liver)(1) and the Mayo Clinic(2) classify the tumor into intrahepatic, perihilar, and distal cholangiocarcinoma. ...
Cholangiocarcinoma, also referred to as cholangiocellular carcinoma (particularly in Japan), develops along the biliary tract.
Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma.
Feng JW, et al. Gastroenterol Hepatol 2019 - Review. PMID 30583874
Cholangiocarcinomas are heterogeneous biliary tract tumors that cause devastating disease. Perihilar cholangiocarcinoma (PHC) is the most common type of biliary tract cancer and are associated with a high mortality. ...Herein, an overview is provided of developments in diagnosis, peri-operative management and surgical treatment among patients with PHCs....
Cholangiocarcinomas are heterogeneous biliary tract tumors that cause devastating disease. Perihilar cholangiocarcinoma (PHC)
2,625 results
Jump to page
Feedback